These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9304332)

  • 1. [The immunoprophylaxis of influenza among elderly persons].
    Marinich IG; Paramonova MS; Erofeeva MK; Maksakova VL; Nikolaeva VM; Naĭkhin AN; Kraĭnova TI; Parkov OV
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):60-4. PubMed ID: 9304332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influenza live attenuated intra-nasal vaccines].
    Weil-Olivier C
    Arch Pediatr; 2010 Jun; 17(6):904-5. PubMed ID: 20654953
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity of inactivated influenza vaccine in residential homes for elderly people.
    Nicholson KG; Baker DJ; Chakraverty P; Farquhar A; Hurd D; Kent J; Litton PA; Smith SH
    Age Ageing; 1992 May; 21(3):182-8. PubMed ID: 1615780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly.
    Stepanova L; Naykhin A; Kolmskog C; Jonson G; Barantceva I; Bichurina M; Kubar O; Linde A
    J Clin Virol; 2002 Apr; 24(3):193-201. PubMed ID: 11856620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative evaluation of the reactogenicity and immunogenicity of inactivated influenza vaccines in the elderly].
    Burtseva EI; Slepushkin AN; Vlasova LN; Oskerko TA; Fedorova GI; Stepnova AI; Beregovskiĭ NA
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):40-5. PubMed ID: 11220963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract]   [Full Text] [Related]  

  • 8. [The evaluation of the epidemiological efficacy of 3-component inactivated influenza vaccines using an intranasal application method].
    Marinich IG; Iaroshevskaia IIu; Konareva AL; Lonskaia NI; Shadrin AS; Salmin LV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):76-8. PubMed ID: 8079581
    [No Abstract]   [Full Text] [Related]  

  • 9. [The reactogenic properties and antigenic activity of inactivated 3-component influenza vaccines used intranasally].
    Erofeeva MK; Maksakova VL; Mikhaĭlov AA; Kostiuchek NV; Marinich IG; Tsaritsyna IM; Shadrin AS; Subbotina TI; Sidorova LV; Voĭtsekhovskaia EM
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):63-5. PubMed ID: 8079572
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.
    Mitchell DK; Ruben FL; Gravenstein S
    Pediatr Infect Dis J; 2005 Oct; 24(10):925-7. PubMed ID: 16220095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of the immune status in specific and nonspecific prophylaxis of influenza in elderly persons].
    Semenenko TA; Sel'kova EP; Gotvianskaia TP; Gaĭdarenko AD; Polezhaeva NA; Evseeva LF; Nikolaeva OG
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (6):24-8. PubMed ID: 16438370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of elderly volunteers with the 1988-89 inactivated whole influenza vaccine: assessment of antibody responses by haemagglutination inhibition and single radial haemolysis tests.
    Iorio AM; Zei T; Neri M; Campitelli L; Castrucci MR; Donatelli I
    Eur J Epidemiol; 1992 Jul; 8(4):491-7. PubMed ID: 1397214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Pavlova LI; Malinovskiĭ AA
    Voen Med Zh; 1997 Feb; 318(2):47-9. PubMed ID: 9148581
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children.
    Bernstein DI; Yan L; Treanor J; Mendelman PM; Belshe R;
    Pediatr Infect Dis J; 2003 Jan; 22(1):28-34. PubMed ID: 12544405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.
    Treanor JJ; Mattison HR; Dumyati G; Yinnon A; Erb S; O'Brien D; Dolin R; Betts RF
    Ann Intern Med; 1992 Oct; 117(8):625-33. PubMed ID: 1530193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The choice of the optimal schedules in the vaccination procedure against influenza in elderly subjects].
    Burtseva EI; Slepushkin AN; Beliaev AL; Kolobukhina LV; Merkulova LN; Boltenko VV; Stepnova AI; Beregovskiĭ NA; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):40-5. PubMed ID: 9783399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z
    Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effectiveness of using the Vaxigrip vaccine from the firm of Pasteur Mérieux Connaught for influenza prevention in organized groups of adults].
    Sharipova IS; Fel'dblium IV; Kuz'minykh SI; Nikolova IV; Padrul' MM; Sharipov MS; Nikul'shin AA; Kol'tsova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):37-41. PubMed ID: 10851988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization.
    Avtushenko SS; Sorokin EM; Zoschenkova NY; Zacharova NG; Naichin AN
    J Biotechnol; 1996 Jan; 44(1-3):21-8. PubMed ID: 8717382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
    Muszkat M; Greenbaum E; Ben-Yehuda A; Oster M; Yeu'l E; Heimann S; Levy R; Friedman G; Zakay-Rones Z
    Vaccine; 2003 Mar; 21(11-12):1180-6. PubMed ID: 12559796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.